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Mackey AL, Andersen LL, Frandsen U, Suetta C, Sjøgaard G.
Distribution of myogenic progenitor cells and myonuclei is altered in
women with vs. those without chronically painful trapezius muscle. J
Appl Physiol 109: 1920–1929, 2010. First published October 7, 2010;
doi:10.1152/japplphysiol.00789.2010.—It is hypothesized that re-
peated recruitment of low-threshold motor units is an underlying
cause of chronic pain in trapezius myalgia. This study investigated the
distribution of satellite cells (SCs), myonuclei, and macrophages in
muscle biopsies from the trapezius muscle of 42 women performing
repetitive manual work, diagnosed with trapezius myalgia (MYA;
44 8 yr; mean SD) and 20 matched healthy controls (CON; 45
9 yr). Our hypothesis was that muscle of MYA, in particular type I
fibers, would demonstrate higher numbers of SCs, myonuclei, and
macrophages compared with CON. SCs were identified on muscle
cross sections by combined immunohistochemical staining for Pax7,
type I myosin, and laminin, allowing the number of SCs associated
with type I and II fibers to be determined. We observed a pattern of
SC distribution in MYA previously only reported for individuals
above 70 yr of age. Compared with CON, MYA demonstrated 19%
more SCs per fiber associated with type I fibers (MYA 0.098  0.039
vs. CON 0.079  0.031; P  0.05) and 40% fewer SCs associated
with type II fibers (MYA 0.047 0.017 vs. CON 0.066 0.035; P
0.05). The finding of similar numbers of macrophages between the
two groups was not in line with our hypothesis and suggests that the
elevated SC content of MYA was not due to heightened inflammatory
cell contents, but rather to provide new myonuclei. The findings of
greater numbers of SCs in type I fibers of muscle subjected to repeated
low-intensity work support our hypothesis and provide new insight
into stimuli capable of regulating SC content.
Pax7; immunohistochemistry; low-threshold motor units; human skel-
etal muscle; macrophages
CHRONIC TENDERNESS AND TIGHTNESS of the upper trapezius mus-
cle, clinically termed trapezius myalgia, is frequent among
women performing repetitive tasks, such as computer work
(18). At a morphological level, findings in biopsies from
myalgic muscle indicate the presence of large type I fibers,
megafibers, poor capillarization, and evidence of disturbed
mitochondrial organization (5, 17, 23, 24), reviewed elsewhere
(16, 46). Supporting the unusual findings regarding type I
fibers in particular is the “Cinderella hypothesis,” put forward
as an explanation for myalgia almost 20 yr ago (16). This is
based on the premise that low-threshold motor units are the
first to be recruited, are continuously active during a sustained
activation of the muscle, and are thus at risk of being damaged
(16, 46). However, whether the extent of this overloading
results in heightened inflammatory and myogenic activity has
not been investigated previously.
Ever since their discovery at the periphery of a frog muscle
fiber almost 50 yr ago (31), there has been growing interest in
satellite cells (SC) as a self-renewing reservoir of myogenic
potential for postnatal regeneration, growth, and maintenance
of skeletal muscle. There is focus not only on the behavior of
SCs in healthy individuals (7, 15, 20, 22, 27, 30, 32, 44, 45),
but in muscle diseases of many kinds (33, 39, 42, 48). For
example, heightened SC activity in patients suffering from
muscle dystrophy has been reported (42, 48). There is also
evidence to suggest that the continuous cycles of degeneration
and regeneration associated with some muscle diseases even-
tually exhaust the reservoir of repair cells, leaving the muscle
with a poorer regenerative capacity (12, 39, 42). In healthy
individuals, the majority of studies investigating SCs have
reported expansion of the SC pool with heavy resistance
training (20, 22, 27, 36, 45), where the role of the new SCs in
donating new myonuclei under conditions of hypertrophy and
repair seems clear. However, evidence is also emerging for
enhanced SC content with lower muscle loads (8, 28, 30, 45),
where injury and hypertrophy are not as evident, supporting a
role for SCs over a broader physiological range. There are,
therefore, good grounds for the hypothesis that SC and myo-
nuclear content are altered in myalgic muscle exposed to
prolonged low-level activation. Such information would not
only provide valuable insight into the pathophysiological spec-
trum of SC activity, but, from a clinical perspective, may
contribute toward a better understanding of the myogenic stress
experienced by painful muscles.
The aim of this study, therefore, was to compare the content
of SCs and myonuclei in biopsies from myalgic muscle with
those from matched healthy controls. In addition, we examined
the content of macrophages, which are known to have both
pro- and anti-inflammatory roles in removing damaged mate-
rial and promoting muscle repair by various means, including
stimulating proliferation of myoblasts (9, 40, 43). In further
support of an association between inflammation and myalgia,
there is recent direct evidence for increased levels of the
proinflammatory cytokine tumor necrosis factor- in the skel-
etal muscle of rats performing low-force, high-repetition tasks
for 12 wk (14), suggesting that chronic repetitive office work
could initiate an inflammatory response in the working mus-
cles. We hypothesized that, compared with controls, myalgic
muscle would 1) contain higher numbers of macrophages, and
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2) be characterized by greater numbers of SCs and myonuclei,
particularly in type I fibers.
MATERIALS AND METHODS
Subjects
A case-control study was performed during the period from Sep-
tember 2005 to March 2006 in Copenhagen, Denmark. The study
design and procedure of recruitment have been described in detail
previously (41). Briefly, 42 female office workers with myalgia in
their trapezius muscle (MYA; 44  8 yr of age, 165  6 cm, 72  15
kg, means  SD) and 20 control women comparable with regard to
job-type, age, weight, and height, but without neck myalgia, (CON;
45 9 yr of age, 167 6 cm, 70 11 kg, means SD) participated.
The participants in both CON and MYA were active in the labor
market and recruited from workplaces with monotonous and repetitive
work tasks, mostly office and computer work. The participants in each
group had to meet a number of self-reported and clinically diagnosed
criteria, which have been described in detail recently (18). Participants
with serious clinical conditions, such as previous trauma, life-threat-
ening diseases, whiplash injury, cardiovascular diseases, or arthritis in
the neck and shoulder were excluded from both groups. All women in
MYA were clinically diagnosed with trapezius myalgia, where the
main criteria for a positive diagnosis were 1) chronic or frequent pain
in the neck area, 2) tightness of the upper trapezius muscle, and
3) palpable tenderness of the upper trapezius muscle (18, 41). All
participants were informed of the purpose and content of the project
and gave written, informed consent to participate in the study, which
conformed to The Declaration of Helsinki and was approved by the
local ethics committee (KF 01–138/04). Muscle mechanical function
and muscle fiber-type composition have recently been reported for the
same group of women with trapezius myalgia compared with matched
controls (1, 3, 5).
Work Exposure
The extent of work exposure was assessed by questionnaire. Par-
ticipants were asked to answer three questions relating to the amount
of work time spent 1) in front of a computer, 2) using the keyboard,
and 3) using the mouse. The answers they could choose from for each
question were as follows: 1) All of the time, 2) ¾ of the time, 3) ½ of
the time, 4) ¼ of the time, 5) Rarely, or 6) Never. The frequencies
were calculated from these questionnaires. Analysis of the answers to
the three questions regarding exposure to computer work revealed a
tendency for MYA to spend more time using the keyboard than CON
(P 0.078). A similar proportion of time spent working at a computer
or actively using the mouse was reported for MYA and CON.
Physical Activity
The participants completed an internet-based questionnaire about
physical activity [a Danish version of the International Physical
Activity Questionnaire Long Form Questionnaire (10)]. Total moder-
ate and vigorous-intensity physical activity performed by the partic-
ipants at work, transportation, housework/gardening, and leisure were
converted to metabolic equivalent per minute per week, according to
the guidelines for data processing of the International Physical Ac-
tivity Questionnaire (17a). Documentation of the amount of physical
activity is presented in Table 1 and shows that, while CON and MYA
performed similar amounts of moderate physical activity, MYA per-
formed a significantly lower amount of vigorous physical activity
compared with CON (P  0.05).
Pain Drawings
Study participants were presented with a body map with five
defined regions: head, neck, upper back, right shoulder, and left
shoulder (Fig. 1). They were asked to mark by pencil for each area
whether pain was present (13). The analysis of the drawings was
blinded regarding case or control. The percentage of individuals
reporting pain for MYA and CON was calculated. As presented in
Fig. 1, 98% of MYA subjects reported pain in the neck region,
compared with 37% in CON. The proportion of MYA individuals
reporting pain in the upper back, and left, and right shoulders ranged
from 32 to 46%, compared with 0–11% in CON.
Table 1. Physical activity
Moderate Vigorous
CON 3,156 2,036 1,824 1,956
MYA 2,749 2,395 670 1,586a
Values are means  SD in metabolic equivalent (MET)  min  wk1. Doc-
umentation is shown of the amount of moderate and vigorous physical activity
performed per week. MYA, trapezius myalgia group; CON, healthy control
group. aMYA  CON (P  0.05).
Fig. 1. A: body map with five regions defined (head, neck, upper back, right
shoulder, and left shoulder) for pain drawings. B: overview of reports of upper
body regional pain in trapezius myalgia (MYA) and healthy control (CON)
groups. Data are presented as percentage of participants reporting pain for each
region.
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Muscle biopsies were extracted with a Bergstrom biopsy needle
from the upper trapezius muscle at the midpoint between the 7th
cervical vertebra and the acromion. Prior inspection with ultrasonog-
raphy was carried out every time to determine the exact biopsy site.
On extraction of the specimen, the fibers were aligned, embedded in
Tissue-Tek, and frozen by immersion in isopentane, precooled to
approximately 160°C by liquid nitrogen. Samples were stored at
80°C. All biopsy samples were assigned a unique identification
number, thus blinding the investigator to the participant’s identity.
Serial transverse sections (10 m) were cut at24°C using a cryostat
and picked up onto SuperFrost Plus glass slides (Menzel-Gläser,
Braunschweig, Germany). The same person (A. L. Mackey) carried
out all subsequent analysis. Biopsies were analyzed in batches, ar-
ranged by an investigator not involved in the analysis, such that each
batch contained biopsies from both groups.
SCs
SC analysis was carried out by microscopic evaluation of cryosec-
tions immunohistochemically stained for Pax7, as previously used by
others (7, 11, 25, 29, 32, 38, 44). A combination of immunoenzymatic
and immunofluorescence methods was developed for this study to
allow staining of Pax7, type I myosin, and laminin on the same
section. All sections were fixed for 5 min with a 5% formaldehyde
solution (Histofix, Histolab, Gothenburg, Sweden). Blocking of non-
specific binding sites was performed by incubation for 1 h with a
freshly prepared blocking buffer [0.05 M Tris-buffered saline (TBS)
containing 0.01% Triton, 1% bovine serum albumin (BSA), 1%
skimmed milk powder, and 0.1% sodium azide]. SCs were labeled
with a mouse anti-Pax7 antibody (cat. no. MO15020; Neuromics,
Edina, MN), diluted 1:100 in the blocking buffer, and incubated
overnight at 4°C. The next day, the slides were washed for 2 10 min
in 0.05 M TBS containing 0.01% Triton. A biotinylated goat anti-
mouse secondary antibody (cat. no. E0433; Dako Denmark, Glostrup,
Denmark) was then applied, followed by Vector Elite ABC horserad-
ish peroxidase kit (cat. no. PK6100; Vector Laboratories, Peterbor-
ough, UK). Horseradish peroxidase activity was visualized with the
Immpact diaminobenzidine substrate (cat. no. SK-4105; Vector Lab-
oratories). The sections were then incubated for 2 h at room temper-
ature with a mixture of 1:100 dilutions (in 0.05 M TBS containing 1%
BSA) of the two primary antibodies mouse anti-A4.951 (cat. no.
A4.951; Developmental Studies Hybridoma Bank, Iowa, IA) and
rabbit anti-laminin (cat. no. Z0098; Dako), for visualization of type I
myosin and laminin, respectively. Alexa Fluor 488 goat anti-rabbit
(Molecular Probes cat. no. A11034; Invitrogen, Taastrup, Denmark)
and Alexa Fluor 568 goat anti-mouse secondary antibodies (Molecu-
lar Probes, cat. no. A11031) were mixed together at concentrations of
1:200 in 0.05 M TBS, containing 1% BSA, and applied to the sections
for 45 min. Washing in two changes of 0.05 M TBS was carried out
between all steps. 4=,6-Diamidino-2-phenylindole (DAPI) in the
mounting medium (Molecular Probes ProLong Gold anti-fade re-
agent, cat. no. P36935) stained the nuclei, rendering type I myosin red,
laminin green, and nuclei blue. Sites of Pax7 antigenicity were stained
brown, visible by light microscopy. See Fig. 2 for an example of this
staining on one of the biopsies from this study.
SC Analysis
The aim of this analysis was to determine the number of Pax7
cells and to distinguish whether they were associated with type I or
type II fibers. To do this, a gray-scale image of the fluorescent laminin
staining was captured (with an Olympus DP71 digital camera,
mounted on an Olympus BX51 microscope using a 4 objective with
a 0.5 camera mount), inverted, and printed out on an A4 page.
Viewing the section with 20 and 40 objectives, Pax7 cells were
identified, and their locations recorded on the respective fibers on the
laminin print. A gray-scale image of the fluorescent type I myosin
staining, captured and inverted in the same manner as the laminin
image, was printed on a transparent A4 sheet. Overlaying this on the
laminin print revealed whether the Pax7 cells were associated with
type I (stained) or type II (unstained) fibers. The number of Pax7 cells
associated with type I or type II fibers was counted separately and
expressed relative to the total number of type I or type II fibers
included in the assessment. The number of Pax7 cells was also
expressed relative to fiber area and as a proportion of the number of
myonuclei.
Fig. 2. Adapted immunohistochemical detection of
Pax7 cells, type I myosin, and laminin on a single
cross section of healthy trapezius muscle (CON
group). In this series of images, three Pax7 cells
(brown) are visible, two of which are associated with
type I fibers (red), and one with a type II fiber
(unstained). Laminin staining (green) defines the
fiber borders. Note the immediate proximity to a
laminin-rich capillary of two of the Pax7 cells in this
image. Scale bar  50 m.
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All measurements relating to myonuclei were made from the
sections stained for the assessment of SCs. On these sections, the
staining for nuclei, laminin, and type I myosin was visible by fluo-
rescence microscopy (Fig. 2). The number of fibers with central nuclei
was determined by viewing each section with a 20 objective and
recording the number of type I fibers containing one or more central
myonuclei. The same assessment was then made for type II fibers. A
nucleus was considered centrally located if a gap between the nucleus
and the laminin-rich basement membrane was visible at this magni-
fication. For measurements relating to the number of myonuclei per
fiber and the myonuclear domain, digital images were captured using
a 20 magnification (0.5 camera mount) with a triple-band filter
adjusted so that laminin and type I fiber staining were visible. Using
the program CellF (Olympus Life and Material Science Europe,
Hamburg, Germany), type I fibers (A4.951) were identified on this
image, and the number of fibers recorded. With the aid of the freehand
drawing tool, the laminin-defined edges of these fibers were delin-
eated manually, and the combined area of the fibers was generated.
Myonuclei were identified individually through the microscope using
a 40 objective, and their location was marked on the image. This
was carried out for all of the marked fibers, and the total number of
myonuclei was recorded. This procedure was repeated for type II
fibers (A4.951). Data generated from this analysis were 1) the mean
fiber area, 2) the number of myonuclei/fiber, and 3) the area of
cytoplasm per myonucleus (myonuclear domain). These data were
generated separately for type I and type II fibers.
Myofiber Remodeling and Cell Activity
Myofiber regeneration was assessed by staining three serial sec-
tions for 1) embryonic myosin, 2) neonatal myosin, and 3) CD56 as an
additional indicator of regeneration and the innervation status of the
fibers (49). After fixation for 5 min in a 5% formaldehyde solution
(Histofix), sections were incubated overnight at 4°C with 1) mouse
anti-embryonic myosin (F1.652; Developmental Studies Hybridoma
Bank), or 2) mouse anti-neonatal myosin (NCL-MHCn; Novocastra,
Newcastle upon Tyne, UK). Both primary antibodies were mixed with
rabbit anti-laminin (cat. no. Z0098; Dako) to define the fiber borders.
Alexa Fluor 488 goat anti-rabbit (Molecular Probes, cat. no. A11034)
and Alexa Fluor 568 goat anti-mouse (Molecular Probes, cat. no.
A11031) secondary antibodies were applied to the sections to visual-
ize primary antibody binding. DAPI in the mounting medium (Mo-
lecular Probes ProLong Gold anti-fade reagent, cat. no. P36935)
stained the nuclei, rendering embryonic myosin and neonatal myosin
red, laminin green, and nuclei blue (see Fig. 3 for example).
3) Staining for CD56 was performed in the same manner, with a
mouse anti-CD56 antibody (cat. no. 347740; Becton Dickinson, San
Jose, CA), but double-stained with Ki67 (cat. no. CP249; Biocare
Medical, Concord, CA) instead of laminin, with the dual purpose of
evaluating the presence of cells in the active phase of the cell cycle
(Ki67), as recently described (29), as well as the proportion of fibers
demonstrating immunoreactivity for the CD56 antigen. The number of
embryonic myosin, neonatal myosin, and CD56 positive fibers was
counted from the respective stainings and expressed as a percentage of
the total number of fibers on that section. For the assessment of actively
dividing cells, Ki67 cells were identified, and whether these cells were
CD56 positive (Ki67CD56) or negative (Ki67CD56) was re-
corded. The values were expressed relative to the number of fibers in the
cross section as cells per 100 fibers. The total number of Ki67 cells per
100 fibers {[(Ki67CD56)  (Ki67CD56)]  100} was also
calculated from these data.
Macrophages
Macrophages were identified on cryosections by using an indirect
double immunofluorescence labeling protocol, as follows. The sec-
tions were incubated simultaneously overnight with a primary anti-
body against macrophages (mouse anti-CD68, cat. no. M0718; Dako)
and the basement membrane component laminin (cat. no. Z0098;
Dako), both diluted in 0.05 M TBS (containing 1% BSA) to a
concentration of 1:100. Visualization of primary antibody binding was
achieved by adding a mixture of the two secondary antibodies Alexa
Fluor 568 goat anti-mouse (Molecular Probes, cat. no. A11031) and
Alexa Fluor 488 goat anti-rabbit (Molecular Probes, cat. no. A11034).
DAPI in the mounting medium (Molecular Probes ProLong Gold
antifade reagent, cat. no. P36931) stained the nuclei, which rendered
macrophages red, laminin green, and nuclei blue (Fig. 4). The relative
number of macrophages was quantified by counting the number of
CD68 cells on the cross section and then expressing this number
relative to the total number of muscle fibers (100).
Statistics
The investigator performing the biopsy analyses was blinded.
Subsequently, the data were unblinded and statistically analyzed by an
investigator not involved in the muscle biopsy analyses. Differences
in the main variables between MYA and CON were tested with
two-way ANOVA. Factors included in the model were group (MYA,
CON), fiber type (types I and II), and group by fiber type. Statistical
significance was accepted at the 0.05 level. Test of one-sided hypoth-
eses was deemed significant if a two-sided P value was 0.10. Data
are presented as means  SD. Regression analysis was performed on
the fiber area and myonuclear number data producing Pearson’s
correlation coefficient for each analysis.
RESULTS
SCs
Thirty-seven biopsies from MYA and 17 biopsies from CON
were considered to be of adequate quality and size to be
included in the analysis. A mean of 627  264 (SD) fibers
(418  167 type I fibers, 209  142 type II fibers) per biopsy
was evaluated for MYA, and a mean of 683  199 (SD) fibers
(439  149 type I fibers, 244  90 type II fibers) per biopsy
was evaluated in the CON group. SCs are presented as Pax7
cells per fiber number, per myofiber area, and as a proportion
of the number of myonuclei (Table 2).
Pax7/fiber. A significant group-by-fiber interaction was ob-
served for the number of Pax7 cells per fiber (P  0.0005),
with a significant main effect of fiber type (P  0.0001). Post
hoc analyses revealed a 19% higher concentration of Pax7 cells
associated with type I fibers in MYA compared with CON
(P 0.0226). Conversely, the number of Pax7 cells associated
with type II fibers was 40% lower in MYA compared with
CON (P  0.0359).
Pax7/area. When corrected for fiber area, a significant
group-by-fiber interaction was observed for the number of
Pax7 cells (P  0.0082), with a significant main effect of fiber
type (P  0.0340). Again, greater numbers of Pax7 cells per
type I fiber were observed in MYA compared with CON (P 
0.0281).
Pax7/myonuclei. A significant group-by-fiber interaction
was observed for the number of Pax7 cells expressed as a
proportion of myonuclei (P  0.0136), with a significant main
effect of fiber type (P 0.0001). The number of Pax7 cells per
type I fiber was elevated in MYA compared with CON (one-
tailed, P  0.0488).
In addition, the number of Pax7 cells associated with type I
fibers was significantly greater than the number observed per
type II fiber for MYA (P 0.0001), but not for CON, for Pax7
1923ALTERED SATELLITE CELL DISTRIBUTION IN MYALGIC MUSCLE
J Appl Physiol • VOL 109 • DECEMBER 2010 • www.jap.org






cells per fiber number, per myofiber area, and as a proportion
of the number of myonuclei.
Myonuclei
A significant group-by-fiber interaction (P  0.0290) and a
tendency for a main effect of fiber type (P  0.0793) were
observed for the number of fibers with centrally located myo-
nuclei (Table 2). Post hoc analyses revealed a significantly
lower proportion of type II fibers with central nuclei in MYA,
compared with MYA type I fibers (P 0.0005) and CON type
II fibers (P  0.0209).
With regard to the number of myonuclei per fiber, a mean of
58  7 fibers [31  3 (SD) type I fibers, and 28  4 type II
fibers] per biopsy was evaluated. A significant group-by-fiber
interaction was observed (P  0.0318), with a significant main
effect of fiber type (P  0.0006). Post hoc testing uncovered a
higher number of myonuclei associated with type I fibers vs.
type II fibers in MYA (P 0.0001) and a tendency for a higher
Fig. 3. Immunohistochemical detection of embry-
onic myosin (F1.652, green; A) or neonatal myosin
(MHCn, green; B), together with laminin (red) and
nuclei (blue) on a cross section of trapezius muscle
from the MYA group. These fibers were rare in the
muscle samples of this study and indicate ongoing
regenerative processes at the time of biopsy sam-
pling. DAPI, 4=,6-diamidino-2-phenylindole. Scale
bars  50 m.
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number of myonuclei per type I fiber in MYA compared with
CON (P  0.0513, one-tailed). Myonuclear domain size dem-
onstrated a significant main effect of fiber type (P  0.0001),
but not group or interaction, with type I fibers displaying a
larger myonuclear domain than type II fibers (Table 2).
Macrophages
The average number of muscle fibers included in the anal-
yses per biopsy sample was 733  429 for CON and 667 
312 for MYA. At baseline, CON and MYA had 28  11 and
26  11 macrophages per 100 muscle fibers, respectively.
These values were not significantly different from each other.
Myofiber Remodeling and Cell Activity
Fisher’s exact test revealed a tendency for a higher preva-
lence of biopsies with one or more embryonic myosin positive
fiber in MYA compared with CON (P  0.089). The number
of biopsies demonstrating embryonic myosin positive fibers
was 0 (out of 19) for the CON group and 7 (out of 42) in the
MYA group. No differences were observed between groups for
the incidence of neonatal positive fibers (only observed in one
biopsy) or CD56 fibers. CD56 fibers were observed in 78%
of CON and 79% of MYA. CON and MYA also demonstrated
similar numbers of biopsies containing one or more
Ki67CD56 cells, Ki67CD56 cells, and total number of
Fig. 4. Series of images of typical immunohisto-
chemical stainings for macrophages (CD68 cells)
and laminin. A, B, and C: series of images of one
section. Row 1: macrophage staining in red. Row 2:
laminin in green. Row 3: combined image of rows 1
and 2. Row 4: combined image of rows 1 and 2 and
DAPI in blue. B: a higher magnification (40) of the
region shown in A (20). C: an example of an
unusually shaped fiber containing a centrally located
nucleus, visible in the merged image C4. Scale
bars  100 m.
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Ki67 cells, expressed per 100 fibers. Ki67CD56 cells
were observed in three of the MYA biopsies and none of CON.
Fiber Area
A tendency for a group-by-fiber interaction (P  0.0587)
and a significant main effect of fiber type (P  0.0001) was
observed for fiber area. Further analyses revealed smaller type
II fibers compared with type I for both MYA and CON (P 
0.0001). A post hoc comparison between type II fiber area of
MYA and CON gave a P value of 0.1215.
Regression analyses of fiber area and the number of myo-
nuclei per fiber revealed a significant strong positive relation-
ship (R: range from 0.53 to 0.91, P 0.05) for both fiber types
in MYA and CON (Fig. 5).
DISCUSSION
The central finding of this study is that type I myofibers in
the trapezius muscle of women exposed to repetitive low-force
tasks and suffering from myalgia have a higher density of SCs
and myonuclei, compared with those of healthy matched con-
trols. A recent study on these same individuals uncovered the
presence of unusually hypertrophied type I muscle fibers,
megafibers, in MYA (5). These fibers, on average larger than
10,000 m2, were present to a significantly higher extent in
MYA compared with CON (5) and potentially belong to
“Cinderella” motor units. The finding of increased SC content
of type I fibers is thus in line with previous suggestions of a
chronic loading of type I fibers in myalgia (16, 23). The MYA
individuals in this study experienced more pain than CON in
their upper back muscles and demonstrated a tendency to spend
more time using the keyboard while performing computer
work than CON. Our findings indicate that painful muscle
fibers under prolonged work exposure have a need for greater
numbers of SCs than muscle not exposed to this pattern of
recruitment.
SCs and Myonuclei
Using an adapted form of SC immunohistochemistry, which
facilitates the determination of the distribution of SCs with
regard to type I and II fibers on a single cryosection, we
observed a greater SC content of type I fibers in MYA than
CON when expressed relative to fiber number and when
corrected for fiber size. The fact that MYA SC number ex-
pressed relative to the number of myonuclei only demonstrated
a tendency to differ from CON is likely due to the elevated
numbers of myonuclei detected in type I fibers in MYA.
According to the myonuclear domain theory, each myonucleus
can support an increasing volume of cytoplasm until a limit is
reached, after which new myonuclei are required, if the fiber is
to expand further. While we observed a stronger positive
correlation between fiber area and myonuclear number for type
II fibers than type I in both MYA and CON, exactly how
tightly coupled these variables are is unclear (6, 22, 36). In
addition to evidence of a poor correlation in mature murine
muscle, it has also been suggested that myonuclear capacity
can become impaired with aging (6). In the context of myalgic
muscle, the hypothesis of a greater load on type I fibers
potentially represents two scenarios for myonuclei: 1) a higher
density of myonuclei is required to sustain a higher rate of
protein turnover, a consequence of the nature of the chronic
loading, or 2) the higher density of myonuclei reflects an
impaired capacity of the existing myonuclei, creating a demand
for additional myonuclei. In either situation, it is plausible that
the role of the elevated SC content in the type I fibers of MYA
in this study is to meet the demand for extra myonuclei.
Furthermore, the negligible number of actively dividing SCs
(Ki67 CD56) at the time of biopsy sampling suggests that
this is a chronic, rather than an acute (29), myogenic response.
In contrast to the greater SC content of type I fibers in MYA,
we observed fewer SCs associated with type II fibers in MYA
compared with CON. When corrected for fiber area or myo-
nuclear number though, this difference was no longer present,
suggesting that our finding of differing distributions in type II
fibers is due to a smaller size or myonuclear density of type II
fibers in MYA. The similar myonuclear content of type II fibers in
MYA and CON does not support the latter, while the outcome of
the statistical analysis on the fiber area data indicates that we
cannot exclude the possibility that MYA have smaller type II
fibers than CON. While we did not have a measure of the
amount of vigorous physical activity performed specifically by
the trapezius muscle in our subjects, the lower amount of
general vigorous physical activity reported by MYA compared
with CON is interesting in relation to type II fibers since, in
contrast to low-threshold type I motor units, the higher thresh-
old type II motor units would only be recruited during vigorous
physical activity. It can be further speculated that the signifi-
cantly lower proportion of type II fibers with central nuclei in
MYA, compared with type II fibers for CON and MYA type I,
tentatively supports the lower exposure to vigorous physical
activity. It could be expected that type II fibers subjected to
Table 2. Muscle fiber and cellular characteristics
All Combined Type I Fibers Type II Fibers
Fiber area, m2
CON 4,579  928 5,010 1,107 3,919  1,129b
MYA 4,638 937 5,193 1,110 3,501  977b
Fibers with central
nuclei, %
CON 3.3  2.5 3.3 2.9 3.6  2.9
MYA 3.1 2.1 3.7 2.8 1.6  2.8a,b
Myonuclei/fiber
CON 2.2  0.4 2.3 0.4 2.1  0.7
MYA 2.3 0.5 2.6 0.6c 2.0  0.6b
Fiber area/myonucleusd,
m2
CON 1,981  256 2,115 307 1,811  189
MYA 1,859 307 2,013 362 1,659  329
Pax7/fiber
CON 0.073  0.028 0.079 0.031 0.066  0.035
MYA 0.082 0.026 0.098 0.039a 0.047  0.017a,b
Pax7/mm2 fiber area
CON 16.0  4.3 15.9 5.6 16.2  5.6
MYA 16.8 4.4 19.3 5.7a 14.3  5.7b
Pax7/myonuclear no., %
CON 2.9  0.7 3.1 1.1 2.7  1.1
MYA 3.3 0.9 3.6 1.1c 2.3  1.1b
Values are means  SD. Data are presented for combined fibers types and
differentiated according to type I and type II fibers. The number of satellite
cells (Pax7) are given, expressed relative to fiber number, mm2 of tissue, and
myonuclear number. The number of fibers with central nuclei, myonuclei per
fiber, and the area surrounding each myonucleus are also shown. aMYA vs.
CON (P 0.05). bType II fibers vs. corresponding value for type I fibers (P
0.001). cMYA vs. CON (one-tailed, P  0.05). dMain effect of fiber type only
(P  0.0001).
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hard physical work would experience more regular cycles of
repair, which would result in the presence of central nuclei in
these fibers. However, this hypothesis requires substantiation,
as the data on vigorous physical activity are self-reported at a
whole body level and not specific for the trapezius muscle. We
are, therefore, currently investigating this in a model in which
the trapezius muscles are specifically targeted with heavy
loading. The lack of difference in the percentage of type I
fibers with central nuclei between MYA and CON is perhaps
not surprising, given that the overloading of type I fibers in
myalgia is at a low level, unlikely to induce muscle damage.
These data are in contrast to a previous report of an increased
prevalence of fibers with central nuclei in male myalgia pa-
tients, compared with controls (21). The reason for this dis-
crepancy is unclear, and it is difficult to compare the two
studies directly, given that the presence of central nuclei
provides an indication of cycles of damage and repair that have
occurred over years, not to mention the different sexes and
nature of repetitive work performed in the two studies. In
agreement with the study by Kadi et al. (21), though, we
observed a tendency for MYA to have more embryonic myo-
sin-positive fibers than CON, indicating active muscle remod-
eling in MYA. In addition to the role of SCs in muscle growth,
repair of skeletal muscle is a well-recognized function of SCs.
Our findings of a greater number of embryonic myosin-positive
fibers in MYA support this function and, together with the
finding of a higher density of myonuclei in type I fibers,
provide a likely explanation for the elevated SC number
observed in MYA type I fibers.
Type I vs. II Fibers
In addition to the differences between the two groups, SC
number was significantly higher in type I fibers compared with
type II fibers for MYA, but not CON, when expressed relative
to fiber number, fiber area, or myonuclear number. It is only
Fig. 5. Graphical illustration of the relationship between fiber area and the number of myonuclei per fiber (MN/F) for type I and II fibers in biopsies from the
trapezius muscle of MYA and CON. 95% confidence limits and 95% prediction limits are denoted by the shaded area and dashed lines, respectively.
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recently that reports of different numbers of SCs associated
with type I or type II fibers have emerged. It appears that the
muscle under investigation and the age of the individuals play
a role in this heterogeneity, since biopsies from the vastus
lateralis of young healthy individuals demonstrate similar num-
bers of SCs in type I and II fibers (19, 44). In contrast, type II
fibers in vastus lateralis, but not deltoid, muscle (45) of healthy
old individuals have been reported to contain fewer SCs
compared with type I fibers (44, 45). Our finding of higher
numbers of SCs in type I fibers compared with type II fibers in
MYA mirrors this pattern observed in older individuals, de-
spite the participants in our study having a mean age of 44 yr,
compared with the mean ages of 76 and 73 yr in other reports
of altered distribution of SCs with fiber type (44, 45), suggest-
ing that inactivity, rather than age per se, plays a more
significant role in the distribution of SCs according to muscle
fiber type. While previous studies on resistance training of
myalgic muscles do not provide any indication of hampered
hypertrophy, and indeed have been shown to ameliorate
chronic muscle pain (2, 35), whether the SC pool of this patient
group can respond in a similar manner to healthy muscle
remains to be established. Furthermore, in the context of
age-associated loss of muscle mass and strength, it would be
valuable to know if the already “aged” distribution of SCs in
myalgic muscle would contribute to a predisposition to, or an
accelerated development of, sarcopenia in this population.
Inflammatory Cells
Infiltration of inflammatory cells of various types is a feature
of pathological, injured, and aging muscle (26, 34, 37, 47). A
role for macrophages in the proliferation and growth of myo-
blasts in vitro is recognized (9), which was the basis for our
hypothesis that MYA muscle would demonstrate higher num-
bers of macrophages than CON. Our finding of similar num-
bers of macrophages and actively dividing cells (Ki67) in
MYA and CON was contrary to our hypothesis and suggests
that heightened inflammatory cell activity is not a feature of
myalgic muscle. Furthermore, in light of the potent stimulus,
macrophages appear to provide for myoblasts (9), the results of
the present study suggest that the greater SC content observed
in MYA is not driven by greater numbers of macrophages, but
is instead more likely to be a response to the demand for extra
myonuclei, as discussed above. It should be noted, however,
that we only examined a broad group of macrophages exhib-
iting immunoreactivity for the CD68 antigen, and we cannot
rule out that investigation of subpopulations of macrophages or
other inflammatory cell types would have resulted in a different
outcome. A further limitation is that types and levels of
cytokines released by the macrophages present in the biopsies
were not evaluated. Despite these limitations, however, it is
clear that our CD68 analysis does not support our hypothesis
that myalgic muscle contains greater numbers of macrophages.
Conclusions
In conclusion, our findings of increased SC and myonuclear
content in type I fibers of myalgic muscle compared with
healthy controls are in line with our hypothesis and provide
strong evidence for heightened myogenic activity, likely aris-
ing out of chronic exposure to low-threshold motor unit acti-
vation. This contributes to the growing body of evidence for
enhancement of the SC pool under conditions in which hyper-
trophy and damage are not evident (8, 28, 30, 45), adding
support to the idea of a role for SCs over a broader physiolog-
ical range than conventionally accepted. Further work is re-
quired to determine whether such modest enhancements of the
SC pool (19% in the present study) have any physiological
importance for the muscle, either in the present stage, or as
these individuals age. An additional feature of the myalgic
muscle investigated in this study was a pattern of distribution
of SCs, according to fiber type previously only observed in
elderly individuals. The consequences of this for the muscle’s
capacity to respond to vigorous physical activity and to resist
sarcopenia remain to be established.
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